MANAMATCH
Dead / Abandoned — Abandoned — no statement of use filed (as of 24 Oct 2022)
What this means for you
This application is over — abandoned 24 Oct 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90539253
- Mark type
- Stylized text
- Filed
- 22 Feb 2021
- Published for opposition
- 25 Jan 2022
- Abandoned
- 24 Oct 2022
- Attorney of record
- Kristen S. Ruisi
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for treating cancer that assist in evaluating and matching common Human Leukocyte Antigen (HLA) with antigen reactivity to potential cancer patients by using predetermined parameters to optimize efficacy and safety
- Class 042 — Scientific and technological services: Development of methodologies in the field of medicine to optimize a match between cell product and patient, matching common Human Leukocyte Antigen (HLA) with antigen reactivity to potential cancer patients in order to enhance the efficacy of Human Leukocyte Antigen (HLA) and specific antigen
Owner
- Mana Therapeutics, Inc., Bethesda, MD, US
- Mana Therapeutics, Inc., Bethesda, MD, US
Prosecution history
- 24 Oct 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 24 Oct 2022 — ABANDONMENT - NO USE STATEMENT FILED
- 22 Mar 2022 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 25 Jan 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Jan 2022 — PUBLISHED FOR OPPOSITION
- 05 Jan 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 21 Dec 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 21 Dec 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 20 Dec 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 20 Dec 2021 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 28 Oct 2021 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 28 Oct 2021 — NON-FINAL ACTION E-MAILED
- 28 Oct 2021 — NON-FINAL ACTION WRITTEN
- 15 Sept 2021 — ASSIGNED TO EXAMINER
- 22 May 2021 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED